DALFAMPRIDINE for Secondary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 85 adverse event reports in the FDA FAERS database where DALFAMPRIDINE was used for Secondary progressive multiple sclerosis.
Most Reported Side Effects for DALFAMPRIDINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Gait disturbance | 8,780 | 15.6% | 35 | 815 |
| Drug ineffective | 6,794 | 12.1% | 20 | 341 |
| Fall | 5,554 | 9.9% | 48 | 1,483 |
| Therapy cessation | 4,580 | 8.2% | 27 | 594 |
| Fatigue | 3,778 | 6.7% | 29 | 441 |
| Balance disorder | 3,753 | 6.7% | 9 | 366 |
| Multiple sclerosis relapse | 3,322 | 5.9% | 29 | 1,234 |
| Condition aggravated | 3,240 | 5.8% | 25 | 409 |
| Dizziness | 2,959 | 5.3% | 5 | 256 |
| Urinary tract infection | 2,757 | 4.9% | 37 | 917 |
| Insomnia | 2,546 | 4.5% | 12 | 165 |
| Mobility decreased | 2,512 | 4.5% | 14 | 262 |
| Asthenia | 2,360 | 4.2% | 36 | 551 |
| Headache | 2,241 | 4.0% | 10 | 206 |
| Multiple sclerosis | 2,224 | 4.0% | 89 | 537 |
Other Indications for DALFAMPRIDINE
Multiple sclerosis (28,787)
Product used for unknown indication (17,590)
Gait disturbance (13,663)
Balance disorder (298)
Relapsing-remitting multiple sclerosis (155)
Muscular weakness (100)
Asthenia (94)
Fatigue (83)
Mobility decreased (74)
Primary progressive multiple sclerosis (71)
Other Drugs Used for Secondary progressive multiple sclerosis
SIPONIMOD (2,265)
OCRELIZUMAB (1,273)
OFATUMUMAB (1,099)
FINGOLIMOD (351)
INTERFERON BETA-1B (146)
RITUXIMAB (131)
NATALIZUMAB (115)
DIMETHYL (96)
INTERFERON BETA-1A (89)
RABEPRAZOLE (86)